The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.
Merlo says COVID-19 related business activity added 10 cents to the adjusted earnings per share.
Independent research finds COVID-19 testing costs can vary by hundreds of dollars per test, with billions of dollars at risk nationwide.
A strong interferon response may lead to harmful cytokine storms.
About 80% of the losses are from cancelled surgeries and over services.
Formulation could cause fewer administration-related reactions than IV Darzalex.
NEMEXIS, an international anti-fraud consulting firm based in Berlin, reported fraud and corruption affecting healthcare and healthcare systems spurred whistleblower activity in half of the 58 countries in the survey.
Popular heartburn medication now in shortage due to COVID-19 test.
ICER's pricing model ranges from $10 to $52,880
The Whole Person Care pilot program has proven to be essential for communities in California and could potentially do the same in communities around the world.
Two-year follow up of FOURIER study in 22,655 patients confirms neurocognitive safety of very low LDL-C levels using a patient self-survey tool.
Minnesota health insurance executive sees healthcare utilization peaks and valleys because of COVID-19.
Dice, a career hub for tech professionals, is offering six months of recruitment benifits for free to aid against COVID-19.
Healthcare providers and payers are keeping an eye on unemployment rates across the country and in communities that have been affected the most because the rates will have an effect on the use of medical services and insurance coverage. Here is a look at some of the economies most affected.
Researchers have reported a signicant and positive relationship between the amount of virus present in a throat swab sample and the severity of COVID-19 disease.
The 3D printable mask is the first of its kind to feature a see-through front plate to help patients feel less isolated and is 100% free to download.
The Coronavirus pandemic has served as the most sobering reality and wake-up call to Americans; all starting with our diets.
FDA alerts public not to use chloroquine and hydroxychloroquine to treat COVID-19, as they are not approved to treat anything other than malaria and auto immune disorders.
The collaboration provides patients in the U.S., Europe and Australia with VR Telehealth Kits that include Pico Headsets with Pre-installed Virtual Reality Therapy.
Could the more than 2.5 million firearms purchased in March lead to questionable suicide rate following COVID-19?
The Managed Healthcare Executive Editorial Board Member explains the fight for the cure or to "flatten the curve" is far from over until we all look at healthcare with a global eye.
Four opinions on what interoperability delay means.
8-1 opinion says ACA obliges federal government to pay.
Agency says the anti-malaria drug can cause heart rhythm problems.
Suppliers claim CBD can help alleviate opioid addiction, cure diseases.
Four tips that will help drive medication adherence during COVID-19.
Addressing the disruption in the payer landscape and the adjustments hospitals and medical groups should make to prepare for compelling events so they don't lose patients and revenue.
